These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Use of the percutaneous left ventricular assist device in patients with severe refractory cardiogenic shock as a bridge to long-term left ventricular assist device implantation. Idelchik GM; Simpson L; Civitello AB; Loyalka P; Gregoric ID; Delgado R; Kar B J Heart Lung Transplant; 2008 Jan; 27(1):106-11. PubMed ID: 18187095 [TBL] [Abstract][Full Text] [Related]
6. [Short and intermediate term clinical outcome in patients with cardiogenic shock treated with aortic counterpulsation]. Fornaro G; Prando MD; Parodi F; Cordero G; Sansa M; Bongo AS; Campi A; Aralda D; Dellavesa P; Aina F; Lazzero M; Cernigliaro C G Ital Cardiol; 1996 Dec; 26(12):1385-99. PubMed ID: 9162668 [TBL] [Abstract][Full Text] [Related]
7. Circulatory support for cardiogenic shock due to acute myocardial infarction: a Canadian experience. Hendry PJ; Masters RG; Mussivand TV; Smith S; Davies RA; Finlay S; Keon WJ Can J Cardiol; 1999 Oct; 15(10):1090-4. PubMed ID: 10523475 [TBL] [Abstract][Full Text] [Related]
8. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. Cheng JM; den Uil CA; Hoeks SE; van der Ent M; Jewbali LS; van Domburg RT; Serruys PW Eur Heart J; 2009 Sep; 30(17):2102-8. PubMed ID: 19617601 [TBL] [Abstract][Full Text] [Related]